Advertisement

Topics

Latest "Texas Center Proton Therapy" News Stories

03:58 EDT 26th April 2018 | BioPortfolio

Here are the most relevant search results for "Texas Center Proton Therapy" found in our extensive news archives from over 250 global news sources.

More Information about Texas Center Proton Therapy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Texas Center Proton Therapy for you to read. Along with our medical data and news we also list Texas Center Proton Therapy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Texas Center Proton Therapy Companies for you to search.

Showing "Texas Center Proton Therapy" News Articles 1–25 of 13,000+

Extremely Relevant

Penn Medicine/Virtua strategic alliance brings first proton therapy to South Jersey

(University of Pennsylvania School of Medicine) Cancer care in South Jersey is about to enter a new era. Penn Medicine, in partnership with Virtua, announced plans to build a new proton facility on the campus of Virtua's acute care hospital, Virtua Voorhees. The new $35 million center, which will allow cancer patients to undergo cutting edge proton therapy in single-room treatments, is expected to...


Penn medicine | virtua strategic alliance brings first proton therapy to south Jersey

(University of Pennsylvania School of Medicine) Cancer care in South Jersey is about to enter a new era. Penn Medicine, in partnership with Virtua, announced plans to build a new proton facility on the campus of Virtua's acute care hospital, Virtua Voorhees. The new $35 million center, which will allow cancer patients to undergo cutting edge proton therapy in single-room treatments, is expected to...

Proton beam therapy finally arrives in UK

28 years after the US first pioneered proton beam therapy at Loma Linda University Medical Center, the UK now has its own centre that will be able to provide this type of treatment to patients. The high-energy proton beam therapy will be available via a private clinic in Newport, Wales, after the company behind it receiving funding from the Welsh Government. Image caption:  ...


Proton therapy center for treating cancer patients coming to Utah

A new cancer treatment technology is one step closer to Salt Lake City. Today Huntsman Cancer Institute at the University of Utah announced a plan to add a proton therapy center to its Cancer Hospital.

Apollo Hospitals selects RayStation for India’s first proton therapy center

Apollo Hospitals, Asia´s foremost integrated healthcare provider, as selected RayStation for a new proton therapy center in Chennai – the first such facility in India.

United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 2025 [Report Updated: 11062017] Prices from USD $1350

United States Proton Therapy market is expected to reach nearly US$ 1 Billion, potentially US$7 Billion by 2025.Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers,decreasing cost of proton therapy treatment,technological advances and market adoption.However, high costs involved in the establishment of the center is likely to rest...

Japan Proton Therapy Market Research Report 2018 [Report Updated: 13022018] Prices from USD $1100

The report titled Japan Proton Therapy Market Research Report 2018 examines the market dynamics, competitive landscape and discusses major trends. The report offers the most uptodate industry data on the actual and potential market situation, and future outlook for proton therapy in Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025. Longterm Growth Projection: ...

Florida Healthcare Law Firm Attorney Dave Davidson Closes Second Proton International Transaction

"Our client, Proton International, works with hospitals and physician groups in the United Statesand internationally to develop one- and two-room proton therapy facilities, Read more...

Proton Therapy Not Better Than IMRT in Lung Cancer

In a randomized trial comparing the two modalities, proton therapy was not superior in reducing the rate of serious lung toxicity Medscape Medical News

IBA and RaySearch to display first online adaptive proton therapy workflow at ESTRO

RaySearch, the global leader in software for cancer treatment, and IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, will make a unique joint presentation at the ESTRO 37 Annual Meeting. The companies will demonstrate their innovative approach to optimizing the patient treatment workflow through the first online adaptive proton therapy workflow.

MD Anderson and RaySearch announce strategic alliance to advance radiation therapy of cancer

(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy through several initiatives, including more precisely targeting of tumors, and improving upon, and making more available, an existing radiation therapy called adaptive radiation thera...

FDA clears Hitachi's proton beam therapy tech

The FDA granted Hitachi 510(k) clearance for its real-time image gating system for proton beam therapy, which is designed for -More- 

AML study reports high response rates with combination targeted therapy

(University of Texas M. D. Anderson Cancer Center) Initial findings from a multi-national open-label phase Ib study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 percent patients say researchers at The University of Texas MD Anderson Cancer Center.

No Reduced Toxicity for Proton Tx vs IMRT in NSCLC (CME/CE)

(MedPage Today) -- Study challenges assumptions about supposed superiority of proton therapy

Relevant

North Texas Genome Center to provide massive DNA sequencing for regional biotech

(University of Texas at Arlington) The University of Texas at Arlington, in partnership with the University of North Texas Health Science Center, is bringing massive genome sequencing capabilities to North Texas through the launch of the North Texas Genome Center housed on the UTA campus. In addition to enhancing healthcare delivery in Texas and the surrounding six-state region, the NTGC will prov...

New Cancer Treatment Technology Coming to Utah

Proton therapy is a type of radiation therapy, a cancer treatment that delivers beams of radiation to shrink a tumor. Proton treatment has been found Read more...

How cancer cells repair themselves following proton beam therapy

New research identifies the specific cellular process that helps cancer cells damaged as a result of proton beam therapy, repair themselves.

First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple

(University of Texas M. D. Anderson Cancer Center) A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such ...

Mevion's proton therapy system wins FDA clearance

Mevion Medical Systems' Mevion S250i proton therapy system was granted 510(k) clearance by the FDA.  -More- 

Deeper look at biopsy exposes mutation ready to ambush drug combination

(University of Texas M. D. Anderson Cancer Center) A powerful resistance mutation that appeared to emerge in melanoma after a patient received a targeted therapy combination, instead was lurking in the tumor all along, primed to thwart treatment before it began, researchers at The University of Texas MD Anderson Cancer Center report online at Cancer Discovery.

New research highlights how cancer cells repair themselves following proton beam therapy

(University of Liverpool) Collaborative research conducted in Liverpool and Oxford, published in The Red Journal, identifies the specific cellular process that helps cancer cells damaged as a result of proton beam therapy, repair themselves.

Europe’s First Compact Proton Accelerator Arrives in the Netherlands

MAASTRO Clinic will be the first HYPERSCAN Pencil Beam Scanning Center in Europe Mevion Medical Systems has delivered the compact accelerator for the MEVION S250i Proton Therapy System® to

Lonza opens world’s largest gene therapy manufacturing plant in Texas

Swiss drug manufacturer Lonza has opened a ‘state-of-the-art’ cell and gene therapy manufacturing facility, the Lonza Houston Center of Excellence....Read More... The post Lonza opens world’s largest gene therapy manufacturing plant in Texas appeared first on Pharmaceutical Technology.

UTHealth receives funding to study stem cell therapy for traumatic injury

(University of Texas Health Science Center at Houston) The University of Texas Health Science Center at Houston (UTHealth) has received funding through a public/private partnership for the first-ever clinical trial investigating a stem cell therapy for early treatment and prevention of complications after severe traumatic injury. The proposed Phase 2 trial is underwritten with $2 million from the ...

Combination therapy strengthens T cells in melanoma pre-clinical study

(University of Texas M. D. Anderson Cancer Center) A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when give in combination, may enhance the immune system's ability to kill melanoma tumors deficient in the tumor suppressor gene PTEN. The study was led by investigators at The University of Texas MD Anderson Cancer Center.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks